Detalhe da pesquisa
1.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep
; 73(12): 271-276, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38547037
2.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(8): 180-188, 2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38421945
3.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36611252
4.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
MMWR Morb Mortal Wkly Rep
; 72(33): 886-892, 2023 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37590187
5.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36921274
6.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36580430
7.
Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
Vaccine
; 41(51): 7581-7586, 2023 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38000964
8.
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study.
Lancet Reg Health Am
; 23: 100530, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37333688
9.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics
; 151(5)2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37026401